• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-543-3p 对帕金森病小鼠模型中 GLT-1 的调控机制。

Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease.

机构信息

Central Laboratory and Department of Neurology, Shunde Hospital , Southern Medical University (The First People's Hospital of Shunde Foshan) , Foshan , 528300 , Guangdong , China.

Key Laboratory of Mental Health of the Ministry of Education , Southern Medical University , Guangzhou , 510515 , Guangdong , China.

出版信息

ACS Chem Neurosci. 2019 Mar 20;10(3):1791-1800. doi: 10.1021/acschemneuro.8b00683. Epub 2019 Feb 7.

DOI:10.1021/acschemneuro.8b00683
PMID:30676715
Abstract

Parkinson's disease (PD) features the degeneration and death of dopamine neurons in the substantia nigra pars compacta and the formation of Lewy bodies that contain α-synuclein. Among the numerous PD etiologies, glutamate excitotoxicity is a research hot spot, and glutamate transporters play key roles in this theory. It has been shown that the expression of the glutamate transporter is regulated by microRNAs. In this study, we found that the levels of expression and function of glutamate transporter type 1 (GLT-1) were significantly reduced and miR-543-3p was upregulated during the development of PD. Furthermore, our results indicated that GLT-1 plays an important role in the pathomechanism of PD. We found that miR-543-3p can suppress the expression and function of GLT-1 in MPP-treated astrocytes and MPTP-treated mice. Inhibition of miR-543-3p can rescue the expression and function of GLT-1 and relieve dyskinesia in the PD model, which suggests that inhibition of miR-543-3p could serve as a potential therapeutic target for PD.

摘要

帕金森病(PD)的特征是黑质致密部多巴胺神经元的退化和死亡,以及包含α-突触核蛋白的路易体的形成。在众多 PD 病因中,谷氨酸兴奋性毒性是一个研究热点,而谷氨酸转运体在该理论中起着关键作用。已经表明,谷氨酸转运体的表达受 microRNAs 调节。在这项研究中,我们发现 PD 发展过程中谷氨酸转运体 1(GLT-1)的表达和功能水平显著降低,miR-543-3p 上调。此外,我们的结果表明 GLT-1 在 PD 的发病机制中起重要作用。我们发现 miR-543-3p 可以抑制 MPP 处理的星形胶质细胞和 MPTP 处理的小鼠中 GLT-1 的表达和功能。抑制 miR-543-3p 可以挽救 GLT-1 的表达和功能,并缓解 PD 模型中的运动障碍,这表明抑制 miR-543-3p 可能成为 PD 的潜在治疗靶点。

相似文献

1
Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease.miR-543-3p 对帕金森病小鼠模型中 GLT-1 的调控机制。
ACS Chem Neurosci. 2019 Mar 20;10(3):1791-1800. doi: 10.1021/acschemneuro.8b00683. Epub 2019 Feb 7.
2
HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2 miR-221-3p binding.HOTAIR 通过升高 NPTX2-miR-221-3p 结合来驱动帕金森病小鼠模型中黑质致密部中脑多巴胺能神经元的自噬。
Aging (Albany NY). 2020 May 12;12(9):7660-7678. doi: 10.18632/aging.103028.
3
miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.miR-101a-3p/ROCK2 轴调节帕金森病模型中的神经元损伤。
Aging (Albany NY). 2024 May 21;16(10):8732-8746. doi: 10.18632/aging.205836.
4
Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.通过在黑质中靶向敲低谷氨酸转运体 GLT-1 生成新型帕金森病小鼠模型。
ACS Chem Neurosci. 2020 Feb 5;11(3):406-417. doi: 10.1021/acschemneuro.9b00609. Epub 2020 Jan 21.
5
Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.在MPTP处理的帕金森病小鼠模型和碘代MPP处理的MN9D细胞中,miR-124的下调调节了钙蛋白酶/细胞周期蛋白依赖性激酶5(calpain/cdk5)信号通路蛋白的表达。
Neuroscience. 2014 Jul 11;272:167-79. doi: 10.1016/j.neuroscience.2014.04.039. Epub 2014 Apr 30.
6
Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.抑制 microRNA-342-3p 通过激活有丝分裂原活化蛋白激酶 1 增加谷氨酸转运体,通过 Wnt 信号通路防止帕金森病小鼠多巴胺能神经元丢失。
J Cell Physiol. 2019 Jun;234(6):9033-9044. doi: 10.1002/jcp.27577. Epub 2018 Oct 26.
7
Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.在帕金森病模型中,京尼平苷通过阻断微小RNA-21/溶酶体相关膜蛋白2A的相互作用来降低α-突触核蛋白。
Brain Res. 2016 Aug 1;1644:98-106. doi: 10.1016/j.brainres.2016.05.011. Epub 2016 May 9.
8
Parkinson's Disease: Exploring Different Animal Model Systems.帕金森病:探索不同的动物模型系统。
Int J Mol Sci. 2023 May 22;24(10):9088. doi: 10.3390/ijms24109088.
9
The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.DJ-1 的去糖基化酶活性减轻多巴胺能细胞中α-突触核蛋白的糖基化和聚集:氧化应激介导的 DJ-1 下调在帕金森病中的作用。
Free Radic Biol Med. 2019 May 1;135:28-37. doi: 10.1016/j.freeradbiomed.2019.02.014. Epub 2019 Feb 20.
10
High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.高通量测序鉴定在果蝇帕金森病模型早期通过靶向神经活性配体受体相互作用途径介导α-突触核蛋白毒性的微小RNA
PLoS One. 2015 Sep 11;10(9):e0137432. doi: 10.1371/journal.pone.0137432. eCollection 2015.

引用本文的文献

1
Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson's disease: A systematic review of preclinical studies.间充质干细胞衍生的细胞外囊泡治疗帕金森病的有效性:临床前研究的系统评价
World J Stem Cells. 2025 Apr 26;17(4):102421. doi: 10.4252/wjsc.v17.i4.102421.
2
Triptolide improves Alzheimer's disease by regulating the NF‑κB signaling pathway through the lncRNA NEAT1/microRNA 361‑3p/TRAF2 axis.雷公藤甲素通过lncRNA NEAT1/微小RNA 361-3p/TRAF2轴调控NF-κB信号通路来改善阿尔茨海默病。
Exp Ther Med. 2023 Aug 1;26(3):440. doi: 10.3892/etm.2023.12139. eCollection 2023 Sep.
3
microRNAs profiling of small extracellular vesicles from midbrain tissue of Parkinson's disease.
帕金森病中脑组织来源的小细胞外囊泡的微小RNA谱分析
Front Mol Neurosci. 2023 Feb 3;16:1090556. doi: 10.3389/fnmol.2023.1090556. eCollection 2023.
4
MicroRNA-mediated regulation of reactive astrocytes in central nervous system diseases.微小RNA介导的中枢神经系统疾病中反应性星形胶质细胞的调控
Front Mol Neurosci. 2023 Jan 12;15:1061343. doi: 10.3389/fnmol.2022.1061343. eCollection 2022.
5
miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease.基于微小RNA和反义寡核苷酸的α-突触核蛋白靶向治疗作为帕金森病的疾病修饰疗法
Front Pharmacol. 2022 Nov 15;13:1034072. doi: 10.3389/fphar.2022.1034072. eCollection 2022.
6
Dysregulation of miR-543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1.miR-543 在帕金森病中的失调:对神经保护基因 SIRT1 的影响。
Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12864. doi: 10.1111/nan.12864. Epub 2022 Nov 26.
7
MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease.微小RNA在帕金森病疾病进展的表观遗传调控中的作用
Front Cell Neurosci. 2022 Sep 16;16:995997. doi: 10.3389/fncel.2022.995997. eCollection 2022.
8
Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.帕金森病中调节性非编码RNA与氧化应激之间的相互作用
Front Aging Neurosci. 2022 Aug 9;14:975248. doi: 10.3389/fnagi.2022.975248. eCollection 2022.
9
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.微小 RNA 改变、作为生物标志物的应用及在神经退行性疾病中的治疗方法。
Int J Mol Sci. 2022 Apr 25;23(9):4718. doi: 10.3390/ijms23094718.
10
Diagnostic Test to Identify Parkinson's Disease from the Blood Sera of Chinese Population: A Cross-Sectional Study.从中国人群血清中识别帕金森病的诊断测试:一项横断面研究。
Parkinsons Dis. 2022 Apr 6;2022:8683877. doi: 10.1155/2022/8683877. eCollection 2022.